Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R-Reference-Cited by-同舟云学术

Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R

Published:2017-10-20 Issue:12 Volume:92 Page:1311-1317
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Tefferi Ayalew¹^ORCID,Lasho Terra L.¹,Patnaik Mrinal M.¹^ORCID,Saeed Lyla¹,Mudireddy Mythri¹^ORCID,Idossa Dame¹,Finke Christy¹,Ketterling Rhett P.²,Pardanani Animesh¹,Gangat Naseema¹

Affiliation:

1. Division of Hematology, Department of Medicine; Mayo Clinic; Rochester Minnesota

2. Division of Cytogenetics, Department of Laboratory Medicine; Mayo Clinic; Rochester Minnesota

Publisher

Wiley

Subject

Hematology

Reference24 articles.

1. Myelodysplastic syndromes: contemporary review and how we treat;Gangat;Am J Hematol.,2016

2. Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and management;Garcia-Manero;Am J Hematol.,2015

3. Comparing the prognostic value of risk stratifying models for patients with lower-risk myelodysplastic syndromes: is one model better?;Zeidan;Am J Hematol.,2015

4. Survival trends in primary myelodysplastic syndromes: a comparative analysis of 1000 patients by year of diagnosis and treatment;Gangat;Blood Cancer J.,2016

5. Dose-reduced versus standard conditioning followed by allogeneic stem-cell transplantation for patients with myelodysplastic syndrome: a prospective randomized phase III study of the EBMT (RICMAC Trial);Kroger;J Clin Oncol.,2017

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular testing in myelodysplastic syndromes;Diagnostic Molecular Pathology;2024

2. Mutation landscape of normal karyotype myelodysplastic syndromes and their prognostic impact;American Journal of Hematology;2023-11-21

3. Network-based clustering unveils interconnected landscapes of genomic and clinical features across myeloid malignancies;2023-10-27

4. Incorporating mutations and bone marrow fibrosis into the revised international prognostic scoring system in myelodysplastic syndromes;Leukemia & Lymphoma;2023-10-22

5. Myeloid NGS Analyses of Paired Samples from Bone Marrow and Peripheral Blood Yield Concordant Results: A Prospective Cohort Analysis of the AGMT Study Group;Cancers;2023-04-14